Clinical results analyze dexamethasone implant effect on macular thickness

Video
Conference|ARVO

Dr. Daniel F. Kiernan discusses key findings of a clinical study analyzing the effect of dexamethasone intracameral drug-delivery suspension on macular thickness based on OCT testing following vitreoretinal surgery.

Dr. Daniel F. Kiernan, a vitreoretinal surgeon at The Eye Associates, Sarasota, Florida, discusses the highlights of his 2021 ARVO virtual presentation on the effect of dexamethasone intracameral drug-delivery suspension on macular thickness based on optical coherence tomography (OCT) testing following vitreoretinal surgery.

See more ARVO coverage

Related Videos
Ramin Tadayoni, MD, speaks with Sheryl Stevenson
Jennifer I. Lim, MD, FARVO, FASRS, Director of Retina Service, University of Illinois at Chicago
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center
Carl D. Regillo, MD, FACS, FASRS, Chief of Retina Service, Wills Eye Hospital, Philadelphia, PA
Arshad Khanani, MD, MA FASRS, on a virtual call
Diana Do, MD, Professor of Ophthalmology, Byers Eye Institute, Stanford University, discusses the PHOTON study results as presented AAO
Related Content
Hemoglobin molecule structure, rendered in pink and purple. Generative AI. Image credit: ©Electro Unicorn – stock.adobe.com

TEASE-3 study: Positive interim data are reported for Stargardt drug

April 25th 2024
Article

Gildeuretinol halts Stargardt disease progression, study results indicate

A researcher sits at a computer. Image credit: ©lightpoet – stock.adobe.com

Interactive vision simulator illustrates the vision loss caused by retinal diseases

April 23rd 2024
Article

The online tool shows vision loss simulations for diabetic macular oedema, diabetic retinopathy, age-related macular degeneration and other retinal diseases

Professor Ramin Tadayoni, MD, PhD. Image courtesy of EURETINA

Retina community mourns sudden loss of Ramin Tadayoni, MD, PhD

April 22nd 2024
Article

Prof Tadayoni was a much-admired leader, researcher, surgeon and EURETINA President

The ZEISS Meditec logo in front of a graph showing a line up. Image credit: ©piter2121 – stock.adobe.com

Carl Zeiss Meditec AG announces completed acquisition of Dutch Ophthalmic Research Center

April 4th 2024
Article

Zeiss has secured regulatory approvals to acquire DORC and will shift focus to integration implementation

A detective looks through a magnifying glass at an eyeball. Image created with Canva AI.

Hemorrhagic unilateral retinopathy: No proven aetiology for rare condition

April 2nd 2024
Article

Multimodal imaging and a systemic work-up failed to identify any underlying disorder for the hemorrhages

A black background with a red line graph going down. Image credit: ©Who is Danny – stock.adobe.com

Increase in the incidence rate of conjunctival melanoma in Australia

March 28th 2024
Article

Investigators analysed the incidence and mortality rates from conjunctival melanoma cases over a 32-year period

© 2024 MJH Life Sciences

All rights reserved.